U.S. Neurosurgical Holdings, Inc.
USNU
$0.8854
$0.00180.20%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 156.29% | 80.58% | 266.15% | 25.91% | -31.67% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 156.29% | 80.58% | 266.15% | 25.91% | -31.67% |
| Operating Income | -156.29% | -80.58% | -266.15% | -25.91% | 31.67% |
| Income Before Tax | -93.33% | 14.87% | -274.02% | -104.43% | 60.21% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -93.33% | 14.87% | -145.67% | -104.71% | 60.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -31.11% | -59.65% |
| Net Income | -128.35% | -0.23% | -188.89% | -128.91% | 60.44% |
| EBIT | -156.29% | -80.58% | -266.15% | -25.91% | 31.67% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -6.21% | 41.27% | -89.86% | -117.09% | 60.92% |
| Normalized Basic EPS | -18.89% | 34.20% | -223.38% | -116.08% | 60.70% |
| EPS Diluted | -6.21% | 41.27% | -89.86% | -117.09% | 60.92% |
| Normalized Diluted EPS | -18.89% | 34.20% | -223.38% | -116.08% | 60.70% |
| Average Basic Shares Outstanding | 115.49% | 70.86% | 51.73% | 68.45% | 1.28% |
| Average Diluted Shares Outstanding | 115.49% | 70.86% | 51.73% | 68.45% | 1.28% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
